Matches in Wikidata for { <http://www.wikidata.org/entity/Q63840772> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q63840772 description "clinical trial" @default.
- Q63840772 description "ensayu clínicu" @default.
- Q63840772 description "klinisch onderzoek" @default.
- Q63840772 description "клінічне випробування" @default.
- Q63840772 name "Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment." @default.
- Q63840772 type Item @default.
- Q63840772 label "Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment." @default.
- Q63840772 prefLabel "Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment." @default.
- Q63840772 P1132 Q63840772-6A640A93-263E-47A0-A21F-FFE30C8B0A1C @default.
- Q63840772 P1476 Q63840772-88E9683B-B007-4347-89FB-6B9555BF95CF @default.
- Q63840772 P17 Q63840772-032CDA89-B3B2-485D-BC91-145116B36744 @default.
- Q63840772 P17 Q63840772-362AB183-083D-4ADE-A613-4A02774D83A3 @default.
- Q63840772 P17 Q63840772-45E10D7C-8314-44A8-977C-775A27401A92 @default.
- Q63840772 P17 Q63840772-549EC1E4-BB02-45A5-8840-1E1985687577 @default.
- Q63840772 P17 Q63840772-6EA5097F-3D7A-42B1-AA5B-BE09E7C96A34 @default.
- Q63840772 P17 Q63840772-8BBF9201-E032-4911-9C83-7FB276BCEB93 @default.
- Q63840772 P17 Q63840772-96D231F3-964A-4C48-AA09-77AF82C5A830 @default.
- Q63840772 P1813 Q63840772-ABC51475-51CC-4A7B-BD71-92D7B498D46D @default.
- Q63840772 P2899 Q63840772-8E648B4F-09DA-44CA-BEAC-7E852F594065 @default.
- Q63840772 P3098 Q63840772-038BFA8D-C741-44D7-8C12-26A1A210E68A @default.
- Q63840772 P31 Q63840772-448B4221-51C2-4A3B-96E8-BC0214205083 @default.
- Q63840772 P4135 Q63840772-40B052D8-B0C4-4823-A624-0ADAFB3DFB3F @default.
- Q63840772 P580 Q63840772-501AE24E-1123-4B98-8B83-3A951F1B1B65 @default.
- Q63840772 P582 Q63840772-0DA1B00C-A5A9-4166-ACE0-D7809FFA6563 @default.
- Q63840772 P6099 Q63840772-B3119D72-43A8-40CA-AB1F-83E6F662EF61 @default.
- Q63840772 P8363 Q63840772-7B07631F-01BA-4456-8BEB-88FAC04294DF @default.
- Q63840772 P1132 "+212" @default.
- Q63840772 P1476 "A Phase II, Double-Blind, Randomised, Placebo-Controlled Study to Assess the Efficacy and Safety of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Combination With Docetaxel, Compared With Placebo in Combination With Docetaxel, in Patients Receiving Second Line Treatment for Locally Advanced or Metastatic Non Small Cell Lung Cancer (Stage IIIB - IV)" @default.
- Q63840772 P17 Q142 @default.
- Q63840772 P17 Q155 @default.
- Q63840772 P17 Q183 @default.
- Q63840772 P17 Q219 @default.
- Q63840772 P17 Q28 @default.
- Q63840772 P17 Q36 @default.
- Q63840772 P17 Q55 @default.
- Q63840772 P1813 "SELECT-2" @default.
- Q63840772 P2899 "+18" @default.
- Q63840772 P3098 "NCT01750281" @default.
- Q63840772 P31 Q30612 @default.
- Q63840772 P4135 "+130" @default.
- Q63840772 P580 "2012-12-18T00:00:00Z" @default.
- Q63840772 P582 "2016-01-27T00:00:00Z" @default.
- Q63840772 P6099 Q42824440 @default.
- Q63840772 P8363 Q78089383 @default.